Skip to main navigation Skip to search Skip to main content

Nitroimidazoles, quinolones and oxazolidinones as fluorine bearing antitubercular clinical candidates

  • Czech Academy of Sciences
  • Konkuk University

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

Tuberculosis is a leading killer of lives worldwide and the global curse of multi-drug resistant tuberculosis is attaining really dangerous levels. Synergistic interaction of HIV and TB is the twin epidemics in resource-limited countries as each potentiate progression of the other. The increasing emergence of MDR-TB and XDR-TB place an immense burden for the treatment of TB with currently available drugs. The situation urgently demands for the discovery of new drugs with novel mode of action and differs in structural features in order to overcome resistance appears in conventional TB therapeutics. The present report covers the discovery of three classes of antituberculosis drugs, Nitroimidazoles, Quinolones and Oxazolidinones, undergoing clinical development with fluorine atom in their structures. Highly electronegative fluorine atom plays a signature role in advancing medicinal innovations as it existence in the drug compounds critically influences metabolic stability and lipophilicity thereby delaying its elimination by the body which results into a long term in vivo efficiency of the drug. Presence of fluorine atom(s) in the drug structures described in this report, has been associated with the several fold increase in the overall potency of the compound as demonstrated since the early discoveries. 6 Fluorinated derivatives from these three classes as pretomanid, delamanid, moxifloxacin, gatifloxacin, linezolid and sutezolid have been discussed with their antituberculosis effects, mode of action, chemical synthetic routes and results of clinical studies.

Original languageEnglish
Pages (from-to)1174-1186
Number of pages13
JournalMini-Reviews in Medicinal Chemistry
Volume15
Issue number14
DOIs
StatePublished - 1 Dec 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antitubercular drugs
  • Delamanid
  • Fluorine-containing drugs
  • Gatifloxacin
  • Linezolid
  • Moxifloxacin
  • Pretomanid
  • Sutezolid

Fingerprint

Dive into the research topics of 'Nitroimidazoles, quinolones and oxazolidinones as fluorine bearing antitubercular clinical candidates'. Together they form a unique fingerprint.

Cite this